Commuters drive past the INTAS pharmaceutical plant in Ahmedabad, India, Friday, Aug. 2, 2024, where U.S. Food and Drug Administration inspectors documented a “cascade of failure” during a 2022 safety inspection. (AP Photo/Ajit Solanki)
(AP Illustration/Peter Hamlin)
An INTAS pharmaceutical manufacturing plant is seen Ahmedabad, India, Friday, Aug. 2, 2024, where U.S. Food and Drug Administration inspectors documented a “cascade of failure” during a 2022 safety inspection. (AP Photo/Ajit Solanki)
FILE - This scanning electron microscope image made available by the Centers for Disease Control and Prevention shows rod-shaped Pseudomonas aeruginosa bacteria, a drug-resistant strain of which was linked to infections from tainted eyedrops from EzriCare and Delsam Phama which were recalled in February 2023. (Janice Haney Carr/Centers for Disease Control and Prevention via AP, File)
FILE - A U.S. Food and Drug Administration building is seen behind FDA logos at a bus stop on the agency's campus in Silver Spring, Md., on Aug. 2, 2018. (AP Photo/Jacquelyn Martin, File)
Dr. Stephen Ostroff, the U.S. Food and Drug Administration's former chief scientist, speaks during an interview in Harrisburg, Pa., on Aug. 20, 2024. (AP Photo/Shelby Lum)